Vaccination of solid-organ transplantation candidates

Clinical Infectious Diseases

Volumn 49, Issue 10, 2009, Pages 1550-1556

  Chow, Jennifer ^a   Golan, Yoav ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; PNEUMOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE 23; PNEUMOCOCCUS VACCINE 7; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE;

ANTIBODY TITER; CHICKENPOX; DIPHTHERIA; DRUG EFFICACY; DRUG SAFETY; GRAFT REJECTION; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; KIDNEY DISEASE; LIVER CIRRHOSIS; MEASLES; MEDICAL INFORMATION; MUMPS; ORGAN TRANSPLANTATION; PERTUSSIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RUBELLA; TETANUS; TREATMENT CONTRAINDICATION; VACCINATION; VERRUCA VULGARIS;

HUMANS; IMMUNOCOMPROMISED HOST; ORGAN TRANSPLANTATION; PREOPERATIVE CARE; VACCINATION;

EID: 72849153034     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/644734     Document Type: Review

References (99)

1. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep 1993; 42(RR-4): 1-18.
2. Broyer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C. Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics 1997; 99:35-39 (Pubitemid 27136599) (Pubitemid 27136599)
3. Duchini A, Hendry RM, Redfield DC, Pockros PJ. Influenza infection in patients before and after liver transplantation. Liver Transpl 2000; 6:531-542 (Pubitemid 30694504) (Pubitemid 30694504)
4. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56(RR-2):1-24.
5. Acott PD, Lee SH, Bitter-Suermann H, Lawen JG, Crocker JF. Infection concomitant with pediatric renal allograft rejection. Transplantation 1996; 62:689-691 (Pubitemid 26313917)
6. Gabriel R, Selwyn S, Brown D, et al. Virus infections and acute renal transplant rejection. Nephron 1976; 16:282-286
7. Kapoor D, Aggarwal SR, Singh NP, Thakur V, Sarin SK. Granulocytemacrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients. J Viral Hepat 1999; 6:405-409 (Pubitemid 29470171) (Pubitemid 29470171)
8. Keane WR, Helderman JH, Luby J, Gailiunas P, Hull AR, Kokko JP. Epidemic renal transplant rejection associated with influenza A/Victoria. Proc Clin Dial Transplant Forum 1978; 8:232-236
9. Keeffe EB, Iwarson S, McMahon BJ, et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998; 27:881-886 (Pubitemid 28103570) (Pubitemid 28103570)
10. Lee SD, Chan CY, Yu MI, et al. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease. J Med Virol 1997; 52:215-218 (Pubitemid 27239323) (Pubitemid 27239323)
11. Magnani G, Falchetti E, Pollini G, et al. Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study. J Heart Lung Transplant 2005; 24:588-592 (Pubitemid 40693882) (Pubitemid 40693882)
12. Chalasani N, Smallwood G, Halcomb J, Fried MW, Boyer TD. Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? Liver Transpl Surg 1998; 4: 128-132
13. Rytel MW, Dailey MP, Schiffman G, Hoffmann RG, Piering WF. Pneumococcal vaccine immunization of patients with renal impairment. Proc Soc Exp Biol Med 1986; 182:468-473 (Pubitemid 16013353)
14. Khan S, Erlichman J, Rand EB. Live-virus immunization after orthotopic liver transplantation. Pediatr Transplant 2006; 10:78-82.
15. Rand EB, McCarthy CA, Whitington PF. Measles vaccination after orthotopic liver transplantation. J Pediatr 1993; 123:87-89 (Pubitemid 23185204)
16. Weinberg A, Horslen SP, Kaufman SS, et al. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant 2006; 6:565-568 (Pubitemid 43382144) (Pubitemid 43382144)
17. Zamora I, Simon JM, Da Silva ME, Piqueras AI. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol 1994;8: 190-192 (Pubitemid 24092256)
18. Guidelines for vaccination of solid-organ transplant candidates and recipients. Am J Transplant 2004; 4(Suppl 10):160-163 (Pubitemid 41218005)
19. Avery RK, Michaels M. Update on immunizations in solid-organ transplant recipients: what clinicians need to know. Am J Transplant 2008;8: 9-14.
20. Centers for Disease Control and Prevention. Recommended adult immunization schedule-United States, October 2007-September 2008. 56th ed. Atlanta: Centers for Disease Control and Prevention, 2007: Q1-Q4.
21. Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solidorgan transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003; 16:357-364 (Pubitemid 36871311) (Pubitemid 36871311)
22. Mawhinney H, Allen IV, Beare JM, et al. Dysgammaglobulinaemia complicated by disseminated measles. Br Med J 1971; 2:380-381
23. Mitus A, Holloway A, Evans AE, Enders JF. Attenuated measles vaccine in children with acute leukemia. Am J Dis Child 1962; 103:413-418
24. Ozaki T, Masuda S, Asano Y, Kondo K, Namazue J, Yamanishi K. Investigation of varicella-zoster virus DNA by the polymerase chain reaction in healthy children with varicella vaccination. J Med Virol 1994; 42:47-51. (Pubitemid 24043053)
25. Galea SA, Sweet A, Beninger P, et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis 2008; 197(Suppl 2):S165-9.
26. Gershon AA, Steinberg SP, Gelb L. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics 1986; 78(Pt 2): 757-762 (Pubitemid 16007079)
27. Blumberg EA, Albano C, Pruett T, et al. The immunogenicity of influenza virus vaccine in solid-organ transplant recipients. Clin Infect Dis 1996; 22:295-302. (Pubitemid 26056158)
28. Blumberg EA, Brozena SC, Stutman P, Wood D, Phan HM, Musher DM. Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Infect Dis 2001; 32:307-310 (Pubitemid 32524805) (Pubitemid 32524805)
29. Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ. Immune response to influenza vaccine in adult liver transplant recipients. Liver Transpl 2001; 7:311-313 (Pubitemid 32331534) (Pubitemid 32331534)
30. Dumot JA, Barnes DS, Younossi Z, et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol 1999; 94:1601-1604 (Pubitemid 29260452) (Pubitemid 29260452)
31. Fraund S, Wagner D, Pethig K, Drescher J, Girgsdies OE, Haverich A. Influenza vaccination in heart transplant recipients. J Heart Lung Transplant 1999; 18:220-225 (Pubitemid 29177899) (Pubitemid 29177899)
32. Huzly D, Neifer S, Reinke P, et al. Routine immunizations in adult renal transplant recipients. Transplantation 1997; 63:839-45.
33. Linnemann CC Jr, First MR, Schiffman G. Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med 1981; 141:1637-1640 (Pubitemid 12234071)
34. Loinaz C, de Juanes JR, Gonzalez EM, et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997; 44:235-238 (Pubitemid 27096045)
35. McCashland TM, Preheim LC, Gentry MJ. Pneumococcal vaccine response in cirrhosis and liver transplantation. J Infect Dis 2000; 181: 757-760 (Pubitemid 30131855) (Pubitemid 30131855)
36. Sokal EM, Ulla L, Otte JB. Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia children. Dig Dis Sci 1992; 37:1250-1252
37. Arslan M, Wiesner RH, Poterucha JJ, Gross JB Jr, Zein NN. Hepatitis A antibodies in liver transplant recipients: evidence for loss of immunity posttransplantation. Liver Transpl 2000; 6:191-195 (Pubitemid 30173999)
38. Arslan M, Wiesner RH, Sievers C, Egan K, Zein NN. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver Transpl 2001; 7:314-320 (Pubitemid 32331535) (Pubitemid 32331535)
39. Gunther M, Stark K, Neuhaus R, Reinke P, Schroder K, Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 2001; 71:477-479 (Pubitemid 32175988)
40. Kumar D, Welsh B, Siegal D, Chen MH, Humar A. Immunogenicity of pneumococcal vaccine in renal transplant recipients-three-year follow-up of a randomized trial. Am J Transplant 2007; 7:633-638 (Pubitemid 46376451) (Pubitemid 46376451)
41. Pedrazzi C, Ghio L, Balloni A, et al. Duration of immunity to diphtheria and tetanus in young kidney transplant patients. Pediatr Transplant 1999; 3:109-114.
42. Sarmiento E, Rodriguez-Hernandez C, Rodriguez-Molina J, et al. Impaired antipneumococcal polysaccharide antibody production and invasive pneumococcal infection following heart transplantation. Int Immunopharmacol 2006; 6:2027-2030
43. Mitwalli A. Responsiveness to hepatitis B vaccine in immunocompromised patients by doubling the dose scheduling. Nephron 1996; 73: 417-420 (Pubitemid 26229695)
44. Plotkin SA. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 2008; 47:401-409
45. Briggs WA, Rozek RJ, Migdal SD, et al. Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. Ann Intern Med 1980; 92:471-477 (Pubitemid 10156687)
46. Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 2000; 61:85-93. (Pubitemid 30191231) (Pubitemid 30191231)
47. Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1998; 17:1075-1080 (Pubitemid 28547275)
48. Edvardsson VO, Flynn JT, Deforest A, et al. Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant 1996; 10(Pt 1):556-560 (Pubitemid 27010899)
49. Kimball P, Verbeke S, Flattery M, Rhodes C, Tolman D. Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients. Transplantation 2000; 69:2449-2451 (Pubitemid 30409021)
50. White-Williams C, Brown R, Kirklin J, et al. Improving clinical practice: should we give influenza vaccinations to heart transplant patients? J Heart Lung Transplant 2006; 25:320-323
51. Phillips MJ, Cameron R, Flowers MA, et al. Posttransplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B. Am J Pathol 1992; 140:1295-1308
52. Kwon CH, Suh KS, Yi NJ, et al. Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation. Pediatr Transplant 2006; 10:479-486
53. Rosman AS, Basu P, Galvin K, Lieber CS. Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trial. Am J Med 1997; 103:217-222 (Pubitemid 27413404) (Pubitemid 27413404)
54. Horlander JC, Boyle N, Manam R, et al. Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation. Am J Med Sci 1999; 318:304-307 (Pubitemid 30349663)
55. Dominguez M, Barcena R, Garcia M, Lopez-Sanroman A, Nuno J. Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list. Liver Transpl 2000; 6:440-442 (Pubitemid 30489116)
56. Goldwater PN. Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine nonresponders. Vaccine 1997; 15:353-356 (Pubitemid 27156154) (Pubitemid 27156154)
57. Denits-Pensy M, Forrest GN, Cross AS, Hise MK. The use of vaccines in adult patients with renal disease. Am J Kidney Dis 2005; 46:997-1011. (Pubitemid 41690226) (Pubitemid 41690226)
58. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis 1999; 179:489-492
59. Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338:286-290 (Pubitemid 28065254) (Pubitemid 28065254)
60. Keeffe E. Hepatitis A in patients with chronic liver disease: severity of illness and prevention with vaccination. J Viral Hepat 2000; 7(Suppl 1): 15-17 (Pubitemid 30337607) (Pubitemid 30337607)
61. Lefilliatre P, Villeneuve JP. Fulminant hepatitis A in patients with chronic liver disease. Can J Public Health 2000; 91:168-170 (Pubitemid 30612209)
62. Amber IJ, Gilbert EM, Schiffman G, Jacobson JA. Increased risk of pneumococcal infections in cardiac transplant recipients. Transplantation 1990; 49:122-125 (Pubitemid 20051599)
63. O'Brien KL, Hochman M, Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? Lancet Infect Dis 2007; 7:597-606.
64. Linnemann CC Jr, First MR, Schiffman G. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med 1986; 146:1554-1556 (Pubitemid 16072325) (Pubitemid 16072325)
65. Kumar D, Rotstein C, Miyata G, Arlen D, Humar A. Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. J Infect Dis 2003; 187:1639-1645 (Pubitemid 36578970) (Pubitemid 36578970)
66. Enke BU, Bokenkamp A, Offner G, Bartmann P, Brodehl J. Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients. Transplantation 1997; 64:237-241 (Pubitemid 27332665) (Pubitemid 27332665)
67. Ghio L, Pedrazzi C, Assael BM, Panuccio A, Foti M, Edefonti A. Immunity to diphtheria and tetanus in a young population on a dialysis regimen or with a renal transplant. J Pediatr 1997; 130:987-989 (Pubitemid 27495130) (Pubitemid 27495130)
68. Balloni A, Assael BM, Ghio L, et al. Immunity to poliomyelitis, diphtheria, and tetanus in pediatric patients before and after renal or liver transplantation. Vaccine 1999; 17:2507-2511 (Pubitemid 29314442) (Pubitemid 29314442)
69. Kretsinger K, Broder KR, Cortese MM, et al; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of TDaP among health-care personnel. MMWR Recomm Rep 2006; 55(RR-17):1-37.
70. Human papillomavirus infection. Am J Transplant 2004; 4(Suppl 10): 95-100.
71. Albat B, Chanez P, Wintrebert P, Michel FB, Godard P, Thevenet A. Influenza following heart transplantation in a patient, an unusual cause of viral pneumonia. Presse Med 1993; 22:174.
72. Apalsch AM, Green M, Ledesma-Medina J, Nour B, Wald ER. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995; 20:394-399
73. Mauch TJ, Bratton S, Myers T, Krane E, Gentry SR, Kashtan CE. Influenza B virus infection in pediatric solid-organ transplant recipients. Pediatrics 1994; 94(Pt 1):225-229 (Pubitemid 24236145)
74. Duchini A, Viernes ME, Nyberg LM, Hendry RM, Pockros PJ. Hepatic decompensation in patients with cirrhosis during infection with influenza A. Arch Intern Med 2000; 160:113-115 (Pubitemid 30040980) (Pubitemid 30040980)
75. Englund JA, Champlin RE, Wyde PR, et al. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 1998; 26:1418-1424
76. Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 2003; 348:867-868 (Pubitemid 36245772) (Pubitemid 36245772)
77. Grekas D, Alivanis P, Kiriazopoulou V, et al. Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol 1993; 31:553-556 (Pubitemid 2007653)
78. Kobashigawa JA, Warner-Stevenson L, Johnson BL, et al. Influenza vaccine does not cause rejection after cardiac transplantation. Transplant Proc 1993; 25:2738-2739 (Pubitemid 23239616)
79. Burbach G, Bienzle U, Stark K, et al. Influenza vaccination in liver transplant recipients. Transplantation 1999; 67:753-755 (Pubitemid 29161719)
80. Lawal A, Basler C, Branch A, Gutierrez J, Schwartz M, Schiano TD. Influenza vaccination in orthotopic liver transplant recipients: absence of postadministration ALT elevation. Am J Transplant 2004; 4:1805-1809 (Pubitemid 39434441) (Pubitemid 39434441)
81. Mack DR, Chartrand SA, Ruby EI, Antonson DL, Shaw BW Jr, Heffron T.G. Influenza vaccination following liver transplantation in children. Liver Transpl Surg 1996; 2:431-437 (Pubitemid 26386862)
82. Mauch TJ, Crouch NA, Freese DK, Braunlin EA, Dunn DL, Kashtan CE. Antibody response of pediatric solid-organ transplant recipients to immunization against influenza virus. J Pediatr 1995; 127:957-960
83. Scharpe J, Evenepoel P, Maes B, et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008; 8: 332-337
84. Admon D, Engelhard D, Strauss N, Goldman N, Zakay-Rones Z. Antibody response to influenza immunization in patients after heart transplantation. Vaccine 1997; 15:1518-1522 (Pubitemid 27402868) (Pubitemid 27402868)
85. Dengler TJ, Strnad N, Buhring I, et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 1998; 66:1340-1347 (Pubitemid 28551017)
86. Stiver HG, Graves P, Meiklejohn G, Schroter G, Eickhoff TC. Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients. Infect Immun 1977; 16:738-741 (Pubitemid 8112737)
87. Frenkel LM, Nielsen K, Garakian A, Cherry JD. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection. Arch Pediatr Adolesc Med 1994; 148:57-60. (Pubitemid 24080704)
88. Ljungman P, Fridell E, Lonnqvist B, et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989; 159:610-615 (Pubitemid 19105613)
89. Lynfield R, Herrin JT, Rubin RH. Varicella in pediatric renal transplant recipients. Pediatrics 1992; 90(Pt 1):216-220
90. Broyer M, Boudailliez B. Varicella vaccine in children with chronic renal insufficiency. Postgrad Med J 1985; 61(Suppl 4):103-106 (Pubitemid 16050943) (Pubitemid 16050943)
91. Kraft JN, Shaw JC. Varicella infection caused by Oka strain vaccine in a heart transplant recipient. Arch Dermatol 2006; 142:943-945
92. Levitsky J, Te HS, Faust TW, Cohen SM. Varicella infection following varicella vaccination in a liver transplant recipient. Am J Transplant 2002; 2:880-882 (Pubitemid 36306845) (Pubitemid 36306845)
93. Luby JP, Ramirez-Ronda C, Rinner S, Hull A, Vergne-Marini P. A longitudinal study of varicella-zoster virus infections in renal transplant recipients. J Infect Dis 1977; 135:659-663 (Pubitemid 8085932)
94. Rand KH, Rasmussen LE, Pollard RB, Arvin A, Merigan TC. Cellular immunity and herpesvirus infections in cardiac-transplant patients. N Engl J Med 1977; 296:1372-1377 (Pubitemid 8127338)
95. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid-organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 2004; 4:108-115 (Pubitemid 38155496) (Pubitemid 38155496)
96. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-2284
97. Centers for Disease Control and Prevention. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices. 57th ed. Atlanta: Centers for Disease Control and Prevention, 2008:1-30.
98. Ihara T, Kamiya H, Torigoe S, Sakurai M, Takahashi M. Viremic phase in a leukemic child after live varicella vaccination. Pediatrics 1992; 89: 147-149
99. Cohen JI. Strategies for herpes zoster vaccination of immunocompromised patients. J Infect Dis 2008; 197(Suppl 2):S237-41.